| SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) Mezzion Pharma Co., Ltd. 2080622 14 Feb 2020 | Not protected: Not accepted | Educational services, namely, seminars in the field of pharmaceuticals... Class 041 Class 041 Education and Entertainment Services Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith. Class 044 Class 044 Medical, Beauty & Agricultural Services Providing information in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues via a website; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues via websites; medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders; medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation. | |